Pharmacokinetics Research on 5-Fluorouracil Magnetic Liposome Nanoparticles (FMLNP) in Rats

ZHANG Yang-de,LIU Xin,PENG Jian

DOI: https://doi.org/10.3969/j.issn.1005-8982.2006.12.003

2006-01-01

Abstract:[Objective] To explore the pharmacokinetics rule of FMLNP in rats and work out the pharmacokinetics parameter and observe its targeting function. [Methods] Three administration types were designed, including injecting free 5-Fu, FMLNP in the absence of magnetic field and in the presence of magnetic field via hepatic artery respectively. The serum and other tissues′ medicine concentration was surveyed at 6 minutes, 10 minutes, 30 minute, 1 hour, 2 hours, 4 hours, 6 hours and 8 hours after medicine was given. Medicine-time distribution curves and area under curve (AUC) bar charts of tissues with three administration types were compared. According to the medicine-time concentration of serum of each group, we found the optimization compartment model and worked out the pharmacokinetics parameter after dealing with 3P87 pharmacokinetics software, then simulated it with MATLAB soft ware in order to check the reliability of 3P87. [Results] Compared group A and B, the peak concentration of medicine increased in targeting site of group C (P 0.01), persistence time prolonged but the peak concentration out of targeting site decreased. FMLNP with magnetic field in targeting site group accorded with three-compartment model but all other groups were two-compartment model. [Conclusion] Treatment with FMLNP via hepatic artery administration in the presence of magnetic force the liver targeting site showed significantly greater targeting and the medicine stayed longer than any other model. FMLNP changed the distribution characteristics of 5-Fu in rat, prolonged its half-life period and elevated its biological availability, which proved its good liver targeting function and slow-release.